Medly
Canada, CA · 4 known investors
Medly is a remote patient monitoring program for cardiology care that connects heart-failure patients with specialists through alert-based monitoring. Its coordinators (nurses or nurse practitioners) triage patient alerts and escalate clinical concerns to the responsible physician, with clinical roles customized per clinic.
Also known as Medly Program · The Medly Program
Investors · 4
.jpeg){kind=logo}
Company profile
researched Aug 2026Medly is a telemonitoring and self-management program for heart failure that was developed by the Centre for Digital Therapeutics at University Health Network (UHN) in Toronto. It has two components: the Medly System, comprising the core monitoring technology, and the Medly Service, the people, processes and tools required to operationalize the system. Patients use a smartphone app together with peripheral devices (a weight scale and blood pressure monitor, Bluetooth-enabled for automatic data transfer) to record weight, blood pressure, heart rate, blood glucose, steps and symptoms on a daily basis, supported by automated phone-call reminders. Readings are analyzed immediately by the Medly algorithm, a proprietary rule-based expert system developed, refined and vetted by heart failure clinicians from the Ted Rogers Centre for Heart Research at the Peter Munk Cardiac Centre, which returns self-care feedback based on personalized thresholds and the patient's prescribed treatment plan — for example advising whether readings are within range, prompting medication, or suggesting the patient contact their heart failure clinic or emergency department.
On the clinician side, a web-based Medly dashboard aggregates patient readings and alert history, current medications, heart failure-related laboratory results and graphical historical trends. An alerts centre summarizes recent patient alerts with the triggering parameters and the feedback message the patient received, and patient profiles allow clinicians to adjust thresholds, medications and lab data remotely. Clinicians can choose to receive all alerts or only the most critical ones via secure email. The Medly Service defines clinical roles that link patients to cardiology specialists: a frontline Medly coordinator (a registered nurse or nurse practitioner) reviews and responds to alerts and acts as first point of contact for clinical concerns and technical troubleshooting, escalating to the Most Responsible Physician (typically a cardiologist), with critical alerts always routed directly to the MRP. The UHN Medly team provides higher-level technical and application support. Role responsibilities vary across the onboarding, ongoing and offboarding phases of the program and are reviewed and customized clinic by clinic.
The Medly application is classified as a Class II Medical Device by Health Canada and is available by prescription or clinician referral only. Beyond heart failure, the patient app supports self-management of one or more chronic conditions including diabetes, chronic obstructive pulmonary disease (COPD), hypertension and mental health, and includes direct access to lab results and health-status trending.
Business model
Medly is delivered as a clinical program built by the Centre for Digital Therapeutics at University Health Network rather than as a consumer product: the patient-facing app requires a clinician referral or prescription, and deployment includes the accompanying service layer of coordinators and workflows that clinics adopt and customize.
Traction
The Medly Android app lists more than 1,000 downloads and continues to receive functional updates, most recently in March 2025.
Latest developments
A March 2025 app release introduced an adaptation of the heart failure module with wellness features for pediatric patients and a new health history section covering labs and medications.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Medly presents itself relative to other heart failure and chronic condition telemonitoring or management systems, emphasizing indefinite program duration, lower cost and algorithm-driven clinical resource efficiency.
The program states it has no set duration, so patients can remain enrolled indefinitely, and positions its cost at one third of traditional heart failure management systems. Data that would normally require a human response is handled by the expert-system algorithm, which the company says allows a single frontline Medly coordinator to manage up to 300 patients daily. The program was developed by a public-sector team of heart failure specialists, researchers, engineers, designers and human factors experts, and is continuously evaluated, with service design and implementation science methods applied to deployments across cardiac care settings.
Technology
The system combines a patient smartphone app, Bluetooth-connected weight scale and blood pressure monitor, and a web-based clinician dashboard. Its core is the Medly algorithm, a proprietary rule-based expert system that analyzes daily readings against personalized thresholds and treatment plans to generate patient self-care feedback and simultaneously trigger clinician alerts when parameters fall outside range. Research on the algorithm's development is published as "Developing healthcare rule-based expert systems: Case study of a heart failure telemonitoring system" (Seto et al. 2012).
Go-to-market
Heart failure patients and, more broadly, patients managing chronic conditions such as diabetes, COPD, hypertension and mental health; on the provider side, cardiology and heart failure clinics and their clinicians, coordinators and cardiologists.
Geography
Based in Toronto, Ontario, Canada, at 200 Elizabeth Street, with the program developed at University Health Network and the Peter Munk Cardiac Centre.
History
The Medly telemonitoring program was developed by the Centre for Digital Therapeutics at University Health Network to assist patients and clinicians with heart failure management; the Medly website carries a 2018-2022 copyright range. Underlying algorithm research dates to at least 2012 (Seto et al.). The patient app, published on Google Play by University Health Network, Toronto, has surpassed 1,000 downloads and was updated in March 2025 with a pediatric adaptation of the heart failure module and a new health history section for labs and medications.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsGoogle Play release notes describe a new adaptation of the heart failure module with wellness for pediatric patients and a new Health History section for labs and medications.
The Medly application is classified as a Class II Medical Device by Health Canada and is available only by prescription or clinician referral.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Medlymedly.ca · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Medly do?
- Medly is a smartphone-based telemonitoring program for heart failure and other chronic conditions, built at University Health Network.
- Who are Medly's investors?
- Medly's investors include Toronto Innovation Acceleration Partners, Ada Ventures, Eka Ventures, FELIX CAPITAL.
- Where is Medly headquartered?
- Medly is headquartered in Canada, CA.